Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756190
What this trial is testing
Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study
Who this might be right for
Nasopharyngeal Carcinoma (NPC)Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 28